Merck (NYSE: MRK) reported its third quarter 2024 earnings results today. Sales grew 4% year-over-year to $16.7 billion. Excluding FX, sales growth
Merck & Company Inc.
-(MRK)
XNYS:MRK
Merck (MRK) swings to profit in Q2 on higher revenues; earnings beat
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported net profit for the second quarter of 2024, on an adjusted basis, compared
MRK Earnings: Merck Q1 2024 profit jumps on 9% revenue growth
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the first quarter of 2024, aided
MRK Earnings: Highlights of Merck’s Q4 2023 financial results
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp fall in adjusted earnings for the fourth quarter of 2023, despite
Merck (MRK) Earnings: 3Q23 Key Numbers
Merck (NYSE: MRK) reported sales of $16 billion for the third quarter of 2023, up 7% from the same period a year
Merck & Co., Inc. Q2 2003 Earnings Conference Call Insights
Key highlights from Merck & Co., Inc. (MRK) Q2 2023 Earnings Concall Management Update: [00:18:54] MRK said it will continue to prioritize
Infographic: Key highlights from Merck’s (MRK) Q2 2023 earnings results
Merck (NYSE: MRK) reported second quarter 2023 earnings results today. Total worldwide sales were $15 billion, up 3% from the same period
MRK Earnings: Highlights of Merck’s Q1 2023 financial results
Pharma firm Merck & Co., Inc. (NYSE: MRK) on Thursday reported lower earnings for the first quarter of 2023, due to a sharp
Merck & Co., Inc. (MRK) Q1 2023 Earnings Call Transcript
Merck & Co., Inc. (NYSE: MRK) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Peter Dannenbaum -- Vice President, Investor Relations Robert
Merck & Co Inc (MRK) Q4 2022 Earnings Call Transcript
Merck & Co Inc (NYSE:MRK) Q4 2022 Earnings Call dated Feb. 02, 2023. Corporate Participants: Peter Dannenbaum -- Vice President, Investor Relations Robert M.
Merck (MRK) Earnings: 4Q22 Key Numbers
Merck (NYSE: MRK) reported fourth quarter 2022 earnings results today. Sales increased 2% year-over-year to $13.8 billion. GAAP net income fell 17%
Merck & Co Inc (MRK) Q3 2022 Earnings Call Transcript
Merck & Co Inc (NYSE:MRK) Q3 2022 Earnings Call dated Oct. 27, 2022. Corporate Participants: Peter Dannenbaum -- Vice President of Investor Relations Robert
Infographic: Highlights of Merck’s (MRK) Q3 2022 earnings
Merck & Co., Inc. (NYSE: MRK) reported a modest increase in adjusted earnings for the third quarter of 2022 when the pharmaceutical
Is Merck & Co. (MRK) a good investment after Q1 earnings?
Merck & Co., Inc. (NYSE: MRK) is recovering from the virus-induced slowdown supported by stable demand across its product line globally, a
Infographic: Highlights of Merck’s (MRK) Q1 2022 earnings
Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than-expected earnings and revenues for the first quarter of 2022. The positive outcome
Merck & Co. Inc. (MRK) Q1 2022 Earnings Call Transcript
Merck & Co. Inc. (NYSE: MRK) Q1 2022 earnings call dated Apr. 28, 2022 Corporate Participants: Peter Dannenbaum -- Vice President of Investor Relations
Merck & Co., Inc. (MRK) Q4 2021 Earnings Call Transcript
Merck & Co., Inc. (NYSE: MRK) Q4 2021 earnings call dated Feb. 03, 2022 Corporate Participants: Peter Dannenbaum -- Vice President of Investor Relations
Infographic: A snapshot of Merck’s Q4 2021 earnings
Pharmaceuticals company Merck & Co., Inc. (NYSE: MRK) has reported stronger-than expected earnings and revenues for the fourth quarter. The positive outcome
Merck & Co., Inc. (MRK) Q3 2021 Earnings Call Transcript
Merck & Co., Inc. (NYSE: MRK) Q3 2021 earnings call dated Oct. 28, 2021 Corporate Participants: Peter Dannenbaum -- Vice President, Investor Relations Robert
Merck beats market estimates in Q3: Infographic
Merck (NYSE: MRK) reported third-quarter 2021 financial results before the regular market hours on Thursday. The pharmaceutical giant reported Q3 revenue of
Merck & Co., Inc. (MRK) Q2 2021 Earnings Call Transcript
Merck & Co., Inc. (NYSE: MRK) Q2 2021 earnings call dated Jul. 29, 2021 Corporate Participants: Peter Dannenbaum -- Vice President, Investor Relations Robert